PURE (PURE Bioscience) ROA %: -212.79% (As of Apr. 2026)


What is PURE Bioscience ROA %?

PURE Bioscience PURE -4.67% ROA % is -212.79% as of Apr. 2026. The stock has 5 warning signs investors should review. Among 1,990 Consumer Packaged Goods companies, PURE Bioscience ranks worse than 98.69% on this metric.

ROA % is calculated as Net Income divided by its average Total Assets over a certain period of time. PURE Bioscience's annualized Net Income for the quarter that ended in Apr. 2026 was $-2.50 Mil. PURE Bioscience's average Total Assets over the quarter that ended in Apr. 2026 was $1.17 Mil. Therefore, PURE Bioscience's annualized ROA % for the quarter that ended in Apr. 2026 was -212.79%.

The historical rank and industry rank for PURE Bioscience's ROA % or its related term are showing as below:

PURE' s ROA % Range Over the Past 10 Years
Min: -290.84   Med: -179   Max: 0.1
Current: -195.24

During the past 13 years, PURE Bioscience's highest ROA % was 0.10%. The lowest was -290.84%. And the median was -179.00%.

PURE's ROA % is ranked worse than
98.69% of 1990 companies
in the Consumer Packaged Goods industry
Industry Median: 3.275 vs PURE: -195.24

PURE Bioscience  (OTCPK:PURE) ROA % Explanation

ROA % measures the rate of return on the total assets (shareholder equity plus liabilities). It measures a firm's efficiency at generating profits from shareholders' equity plus its liabilities. ROA % shows how well a company uses what it has to generate earnings. ROA %s can vary drastically across industries. Therefore, ROA % should not be used to compare companies in different industries. For retailers, a ROA % of higher than 5% is expected. For example, Wal-Mart (WMT) has a ROA % of about 8% as of 2012. For banks, ROA % is close to their interest spread. A bank’s ROA % is typically well under 2%.

Similar to ROE, ROA % is affected by profit margins and asset turnover. This can be seen from the Du Pont Formula:

ROA %(Q: Apr. 2026 )
=Net Income/Total Assets
=-2.496/1.173
=(Net Income / Revenue)*(Revenue / Total Assets)
=(-2.496 / 2.024)*(2.024 / 1.173)
=Net Margin %*Asset Turnover
=-123.32 %*1.7255
=-212.79 %

Note: The Net Income data used here is four times the quarterly (Apr. 2026) net income data. The Revenue data used here is four times the quarterly (Apr. 2026) revenue data.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Be Aware

Like ROE, ROA % is calculated with only 12 months data. Fluctuations in the company's earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective. ROA % can be affected by events such as stock buyback or issuance, and by goodwill, a company's tax rate and its interest payment. ROA % may not reflect the true earning power of the assets. A more accurate measurement is ROC % (ROC).

Many analysts argue the higher return the better. Buffett states that really high ROA % may indicate vulnerability in the durability of the competitive advantage.

E.g. Raising $43b to take on KO is impossible, but $1.7b to take on Moody's is. Although Moody's ROA % and underlying economics is far superior to Coca Cola, the durability is far weaker because of lower entry cost.


PURE Bioscience ROA % Related Terms


PURE Bioscience ROA % Historical Data

* Premium members only.

The historical data trend for PURE Bioscience's ROA % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

PURE Bioscience ROA % Chart

PURE Bioscience Annual Data
Trend Jul16 Jul17 Jul18 Jul19 Jul20 Jul21 Jul22 Jul23 Jul24 Jul25
ROA %
Get a 7-Day Free Trial Premium Member Only Premium Member Only -43.65 -79.46 -125.57 -253.50 -255.76

PURE Bioscience Quarterly Data
Jul21 Oct21 Jan22 Apr22 Jul22 Oct22 Jan23 Apr23 Jul23 Oct23 Jan24 Apr24 Jul24 Oct24 Jan25 Apr25 Jul25 Oct25 Jan26 Apr26
ROA % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -284.49 -125.58 -165.42 -318.14 -212.79

PURE vs RAY, DSY, TANH: ROA % Comparison

For the Household & Personal Products subindustry, PURE Bioscience's ROA %, along with its competitors' market caps and ROA % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


PURE Bioscience ROA % vs Consumer Packaged Goods Industry

For the Consumer Packaged Goods industry and Consumer Defensive sector, PURE Bioscience's ROA % distribution charts can be found below:

* The bar in red indicates where PURE Bioscience's ROA % falls into.



PURE Bioscience ROA % Calculation

PURE Bioscience's annualized ROA % for the fiscal year that ended in Jul. 2025 is calculated as:

ROA %=Net Income (A: Jul. 2025 )/( (Total Assets (A: Jul. 2024 )+Total Assets (A: Jul. 2025 ))/ count )
=-2.399/( (0.818+1.058)/ 2 )
=-2.399/0.938
=-255.76 %

PURE Bioscience's annualized ROA % for the quarter that ended in Apr. 2026 is calculated as:

ROA %=Net Income (Q: Apr. 2026 )/( (Total Assets (Q: Jan. 2026 )+Total Assets (Q: Apr. 2026 ))/ count )
=-2.496/( (0.788+1.558)/ 2 )
=-2.496/1.173
=-212.79 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of annual ROA %, the net income of the last fiscal year and the average total assets over the fiscal year are used. In calculating the quarterly data, the Net Income data used here is four times the quarterly (Apr. 2026) net income data. ROA % is displayed in the 30-year financial page.

Frequently Asked Questions Learn more about ROA % →
What does a ROA % of -212.79% mean?
PURE Bioscience (PURE) has a ROA % of -212.79% as of Apr. 2026. Return on assets is the ratio of current-period net income to average two-period total assets. View historical data on PURE Bioscience and its competitors. According to the industry distribution chart, PURE Bioscience ranks #1964 out of 1990 companies in the Consumer Packaged Goods industry, placing it in the top 98.7%.
Is PURE Bioscience's ROA % too high?
PURE Bioscience's current ROA % is -212.79%. Based on the distribution chart, PURE Bioscience ranks #1964 out of 1990 companies in the Consumer Packaged Goods industry, which is in the bottom quartile relative to peers.
How does PURE Bioscience's ROA % compare to RAY and DSY?
According to the Consumer Packaged Goods industry distribution chart, PURE Bioscience ranks #1964 out of 1990 companies for ROA %. This places PURE Bioscience in the lower half of its industry. The industry median ROA % is 3.28. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good ROA % for a Consumer Packaged Goods company?
The median ROA % among Consumer Packaged Goods companies is 3.28, based on 1,990 companies in the industry. Companies in the top quartile (top 25%) have a ROA % significantly above this median, while those in the bottom quartile fall well below. However, ROA % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high ROA % mean?
A high ROA % can signal that a stock is expensive relative to its fundamentals. Return on assets is the ratio of current-period net income to average two-period total assets. View historical data on PURE Bioscience and its competitors. For the Consumer Packaged Goods industry, the median ROA % is 3.28 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. PURE Bioscience's current ROA % is -212.79%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is PURE Bioscience stock overvalued right now?
Based on GuruFocus' analysis, PURE Bioscience (PURE) is currently considered Possible Value Trap. The stock's GF Value™ is $0.10, compared to a current price of $0.07 — trading 33.3% below its estimated fair value. The current ROA % is -212.79%. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is ROA % calculated?
ROA % is calculated from a company's financial statements. For PURE Bioscience (PURE), the current ROA % is -212.79% as of Apr. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

PURE Bioscience Business Description

Address 771 Jamacha Road, No. 512, El Cajon, CA, USA, 92019
PURE Bioscience Inc is engaged in developing and commercializing proprietary antimicrobial products. The company's technology platform is based on patented stabilized ionic silver, and its initial products contain silver dihydrogen citrate, or SDC. It offers PURE Hard Surface as a food contact surface sanitizer and disinfectant to restaurant chains, food processors and food transportation companies and PURE Control as a direct food contact processing aid. It also manufactures and sells SDC-based products for end use, and products preserved with SDC and SDC as a raw material ingredient for manufacturing use. The company generates revenue from the sale of its antimicrobial products.